Maya Livio
Southwest of Black Mesa and north of Cerro Verde, Cibola County, New Mexico, 2015. License: CC0.
Notes
1
Walter De Maria, “The Lightning Field,” Artforum 18, no. 8 (April 1980). All section headings in…
Blog
-
Instagram tests new layout that puts the spotlight on Reels and DMs
Instagram head Adam Mosseri has announced that as part of a test, some Instagram users will be able to try a new menu bar in the app with a different arrangement of tabs. Notably, the new menu bar has dedicated tabs for both Reels and DMs, two of…
Continue Reading
-
Two greenish comets are streaking across the night sky this month
Two greenish-hued comets are swinging through the inner solar system this fall, offering a rare chance to spot them in the coming weeks.
The comets, named C/2025 A6 (Lemmon) and C/2025 R2 (SWAN), are visible from the Northern Hemisphere now as…
Continue Reading
-
Violence erupts in eastern Pakistan as Islamists try to march on capital for pro-Palestinian rally
Violence in Lahore as cops block pro-Palestine march to IslamabadLAHORE: Violent clashes erupted Friday between police and Islamists in Pakistan’s eastern city of Lahore after security forces tried to stop thousands of demonstrators from…
Continue Reading
-
What is Nvidia, the world’s leading AI chipmaker entangled in US-China trade tensions?
Tech giant Nvidia is the world’s leading artificial-intelligence chipmaker, but the company’s success has also put it in the crossfire of trade tensions.
The Santa Clara, California-based company, which is approaching a market capitalization of $5 trillion, has seen rapid growth due to its chips, which are predominantly used to power massive data centers used by other tech firms, like OpenAI, the creator of popular AI chatbot ChatGPT.
But Nvidia’s leading technology has been used as a negotiating tool in President Donald Trump’s trade spat with China, which was kickstarted by Trump’s sweeping tariffs in April and has escalated over rare earth mineral disputes.
It’s further complicated Nvidia’s relationship with China, where it was doing roughly 25% of its graphics processing unit sales, estimates Gil Luria, head of technology research at D.A. Davidson. Nvidia’s popularity has also embroiled the company in a steep controversy for potentially allowing China to skirt around export restrictions as trade tensions continue.
“Nvidia has gotten caught in the middle of two very important things: a trade dispute between China and the United States … but more importantly, AI has become a matter of national security,” Luria said.
Nvidia CEO Jensen Huang has argued that restricting sales of American AI chips will ultimately enable Chinese developers to create their own alternatives.
Huang, 62, was born in Taiwan, and at age 9 was sent by his parents to live in Tacoma, Washington. In 1993, the Oregon State and Stanford University grad co-founded Nvidia, which started as a graphics-based processing company.
Huang — who is worth $167 billion, according to the Bloomberg Billionaires Index — has been treated as a rockstar in Taiwan for his success in the AI chips race, and previously worked as a microprocessor designer at now-competitor AMD.
“It’s really unusual to have somebody who can go from starting what was at the time a very small tech startup and throw it to the extraordinary level of success that Nvidia has grown to,” John Villasenor, a nonresident senior fellow at Brookings Institution and professor at the University of California, Los Angeles, said of Huang.
Nvidia powers the data centers that support AI technology and has been the go-to provider of those chips.
Nvidia essentially created the architecture for anyone who develops AI, leading to a surge in demand for its technology, according to Arun Sundararajan, a professor of technology, operations and statistics at NYU Stern School of Business.
The company said in September that it would invest up to $100 billion in OpenAI and provide it with data center chips as soon as late 2026.
Nvidia is competing with AMD for deals with partners like OpenAI, which said Monday it would use 6 gigawatts of AMD chips to power OpenAI’s data centers.
“The competition has undeniably arrived. Customers will choose the best technology stack for running the world’s most popular commercial applications and open-source models. We’ll continue to work to earn the trust and support of mainstream developers everywhere,” an Nvidia spokesperson said in a statement shared with CNN.
In recent years, the US government has sought to restrict Chinese access to American technology to slow Beijing’s progress on AI, thus allowing the United States to take the lead. Trump continued the trend in April, when he restricted China’s access to chips, including Nvidia’s H20, as part of his trade war.
Such restrictions on the sale of chips offended China, Luria said, and ultimately led to Beijing limiting the purchase of chips to their companies.
But the White House recently reversed their position.
“You want to sell the Chinese enough that their developers get addicted to the American technology stack,” Commerce Secretary Howard Lutnick said in July.
Trump in August greenlit sales of chips to China in an agreement with US chipmakers. Nvidia and AMD, Trump said, would give 15% of revenue from China sales to the US in exchange for export licenses. That includes giving China access to Nvidia’s H20 chips, which were released in 2024 to maintain access to the Chinese market following strict export controls.
But Beijing seemed unimpressed and trade tensions have only escalated since the start of a tit-for-tat trade war in April.
China has since increased import restrictions on US chips, including Nvidia’s processors. Trump said Friday on Truth Social that he would impose a 100% tariff on China “over and above any Tariff they are currently paying” beginning November 1 over export controls on rare earth minerals.
“Where this all gets resolved is unclear,” Luria said, because China believes “that stopping the sale of Nvidia chips into China creates some leverage on the US in the negotiation.”
Commerce Department officials are investigating whether Nvidia’s customer, Singapore-based Megaspeed, is helping China sidestep export restrictions for access to Nvidia’s tech, according to a report from the New York Times. CNN has not independently verified the Times’ reporting.
Nvidia did not respond to CNN’s request for comment.
And Nvidia’s H20 chips are widely believed to have contributed to DeepSeek, an advanced Chinese AI model that shook Silicon Valley upon its release earlier this year, raising concerns that China was further ahead on AI than previously understood.
China could also gain access to the chips on the black market, since another country could buy Nvidia’s chips and resell them to China, Sundararajan said.
“The bigger issue is if we push harder to restrict global access to Nvidia’s products, can that be counterproductive? Because it forces these countries to speed up their own pace of innovation,” Sundararajan said.
Continue Reading
-
New Jumanji Movie to Shoot in November, Brittany O’Grady Joins
Jumanji is back in game play mode as Sony’s latest sequel of its hit franchise heads toward a November start of production in Los Angeles.
Dwayne Johnson, Kevin Hart, Jack Black and Karen Gillan are returning to star in the feature,…
Continue Reading
-
Single psilocybin dose provides long-lasting relief from depression
Psilocybin is a natural psychedelic compound found in certain mushrooms that affects mood and perception. In a new study, researchers found that a single dose of psilocybin quieted chronic pain and depression-like behavior within 24 hours.
The…
Continue Reading
-
Hackers Exploit LFI Flaw in File-Sharing Platforms
Attack Surface Management
,
Security Operations
…Continue Reading
-
MaxSun’s wild new liquid-cooled dual GPU card packs 48GB of memory and might just bend workstation logic to its will
- MaxSun design revives long-abandoned dual-GPU engineering with modern cooling
- Each slim card manages 48GB of memory and dual GPUs in tight spaces
- MaxSun Intel Arc Pro B60 48G Turbo Edition allows dense GPU stacking across full PCIe 5.0 bandwidth
Continue Reading
-
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
AstraZeneca today announces a historic agreement with President Donald J. Trump’s administration to lower the cost of prescription medicines for American patients while preserving America’s cutting-edge biopharmaceutical innovation.
At a landmark event at the White House, AstraZeneca CEO Pascal Soriot joined President Trump and members of his Administration to confirm the Company voluntarily met all requests set out in the President’s July 31st letter. The Company agrees to a range of measures which will enable American patients to access medicines at prices that are equalized with those available in wealthy countries.
As part of the agreement, AstraZeneca will provide Direct-to-Consumer (DTC) sales to eligible patients with prescriptions for chronic diseases at a discount of up to 80% off list prices. AstraZeneca will participate in the TrumpRx.gov direct purchasing platform, which will allow patients to purchase medicines at a reduced cash price from AstraZeneca.
AstraZeneca has also reached an agreement with the US Department of Commerce to delay Section 232 tariffs for three years, enabling the Company to fully onshore medicines manufacturing so that all of its medicines sold in America are made in America. This will be achieved through the Company’s recently announced $50 billion investment in US medicines manufacturing and R&D over the next five years to help deliver $80 billion in Total Revenue by 2030, 50% of which is expected to be generated in the US.
Pascal Soriot, Chief Executive Officer, AstraZeneca, said: “Every year AstraZeneca treats millions of Americans living with cancer and chronic diseases and, as a result of today’s agreement, many patients will access life-changing medicines at lower prices. This new approach also helps safeguard America’s pioneering role as a global powerhouse in innovation and developing the next generation of medicines. It is now essential other wealthy countries step up their contribution to fund innovation.”
AstraZeneca’s commitment to the US and American patients is further reflected in the Company’s largest single investment in a manufacturing facility to date, where the Company broke ground yesterday in Virginia. This facility will support AstraZeneca’s weight management and metabolic portfolio and our leading antibody drug conjugate cancer pipeline. Additionally, a newly expanded manufacturing facility in Coppell, Texas, will officially open next week. Looking ahead, AstraZeneca will open a cell therapy manufacturing facility in Rockville, Maryland early next year and its second major R&D centre in Cambridge, Massachusetts will open in late 2026.
The US is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing and commercial sites. The Company’s US workforce exceeds more than 25,000 people and supports more than 100,000 jobs overall across the country. In 2025, AstraZeneca created approximately $20 billion of overall value to the American economy.
Notes
AstraZeneca’s agreement with US Government
This is the second agreement that a pharmaceutical company has made with the US Department of Health and Human Services to lower the cost of medicines for American patients in the past two weeks. Specific terms of this agreement remain confidential.AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on social media @AstraZeneca.
Media Inquiries
Fiona Cookson
+1 (212) 814-3923
US Media Mailbox: usmediateam@astrazeneca.com
Continue Reading